Therapeutic Potential of Transfer Factor

Abstract

The ability of a low-molecular-weight material from sensitized lymphocytes to transfer cell-mediated immune responses to previously unreactive recipients was reported many years ago.¹ During the past decade, there have been several investigations into the possibility that this form of passive sensitization might be efficacious in patients with cancer, autoimmune diseases, immunodeficiency syndromes, or a variety of inflammatory disorders of uncertain origin. The reports have been promising but inconclusive; either too few patients were studied or the "transfer factor" was used in combination with other agents that may have produced similar results.It is still too early to state that transfer . . .